Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 613 to 621 of 621 entries
Sorted by: Best Match Show Resources per page
Does Sleep Position Influence Sleep-Disordered Breathing in Infants With Cleft Palate: A Feasibility Study?.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association

Murray CS, Walsh T, Bannister T, Metryka A, Davies K, Lin YL, Williamson P, Callery P, O'Brien K, Shaw W, Bruce I.
PMID: 33792409
Cleft Palate Craniofac J. 2021 Apr 01;10556656211003459. doi: 10.1177/10556656211003459. Epub 2021 Apr 01.

OBJECTIVE: Cleft palate (CP) can affect breathing, leading to sleep-disordered breathing (SDB). Sleep position can affect SDB, but the optimum sleep position for infants with CP is unknown. We aimed to determine the design of a pragmatic study to...

Cite
Murray CS, Walsh T, Bannister T, et al. Does Sleep Position Influence Sleep-Disordered Breathing in Infants With Cleft Palate: A Feasibility Study?. Cleft Palate Craniofac J. 2021;10556656211003459doi: 10.1177/10556656211003459.
Murray, C. S., Walsh, T., Bannister, T., Metryka, A., Davies, K., Lin, Y. L., Williamson, P., Callery, P., O'Brien, K., Shaw, W., Bruce, I. (2021). Does Sleep Position Influence Sleep-Disordered Breathing in Infants With Cleft Palate: A Feasibility Study?. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 10556656211003459. https://doi.org/10.1177/10556656211003459
Murray, Clare S, et al. "Does Sleep Position Influence Sleep-Disordered Breathing in Infants With Cleft Palate: A Feasibility Study?." The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association vol. (2021): 10556656211003459. doi: https://doi.org/10.1177/10556656211003459
Murray CS, Walsh T, Bannister T, Metryka A, Davies K, Lin YL, Williamson P, Callery P, O'Brien K, Shaw W, Bruce I. Does Sleep Position Influence Sleep-Disordered Breathing in Infants With Cleft Palate: A Feasibility Study?. Cleft Palate Craniofac J. 2021 Apr 01;10556656211003459. doi: 10.1177/10556656211003459. Epub 2021 Apr 01. PMID: 33792409.
Copy Download .nbib Format: NLM
Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer.

The Annals of thoracic surgery

Olive JK, Zhou N, Mitchell KG, Corsini EM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB.
PMID: 33774003
Ann Thorac Surg. 2021 Mar 25; doi: 10.1016/j.athoracsur.2021.03.034. Epub 2021 Mar 25.

BACKGROUND: Psychiatric comorbidities (PCs) have been associated with poor surgical outcomes in several malignancies. However, the impact of PCs on surgical outcomes for non-small cell lung cancer (NSCLC) remains largely unknown.METHODS: NSCLC patients who underwent pulmonary resection at a...

Cite
Olive JK, Zhou N, Mitchell KG, et al. Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer. Ann Thorac Surg. 2021;doi: 10.1016/j.athoracsur.2021.03.034.
Olive, J. K., Zhou, N., Mitchell, K. G., Corsini, E. M., Hofstetter, W. L., Mehran, R. J., Rice, D. C., Sepesi, B., Swisher, S. G., Vaporciyan, A. A., Walsh, G. L., & Antonoff, M. B. (2021). Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer. The Annals of thoracic surgery, . https://doi.org/10.1016/j.athoracsur.2021.03.034
Olive, Jacqueline K, et al. "Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer." The Annals of thoracic surgery vol. (2021). doi: https://doi.org/10.1016/j.athoracsur.2021.03.034
Olive JK, Zhou N, Mitchell KG, Corsini EM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer. Ann Thorac Surg. 2021 Mar 25; doi: 10.1016/j.athoracsur.2021.03.034. Epub 2021 Mar 25. PMID: 33774003.
Copy Download .nbib Format: NLM
Histoplasmosis in an off-trail Hiker receiving ustekinumab: Implications for Preventive and diagnostic strategies for patients receiving anti-IL-12/23 therapy.

Medical mycology case reports

Huang YH, Magleby R, Rao R, Walsh TJ, Singh HK.
PMID: 33816098
Med Mycol Case Rep. 2021 Mar 13;32:43-46. doi: 10.1016/j.mmcr.2021.03.004. eCollection 2021 Jun.

Ustekinumab, an IL-12/23 inhibitor, is an important agent in treatment of inflammatory bowel disease and psoriasis. Clinical trials have not demonstrated significantly increased infection risk with ustekinumab. We report a case of disseminated histoplasmosis in the setting of ustekinumab...

Cite
Huang YH, Magleby R, Rao R, et al. Histoplasmosis in an off-trail Hiker receiving ustekinumab: Implications for Preventive and diagnostic strategies for patients receiving anti-IL-12/23 therapy. Med Mycol Case Rep. 2021;32:43-46doi: 10.1016/j.mmcr.2021.03.004.
Huang, Y. H., Magleby, R., Rao, R., Walsh, T. J., & Singh, H. K. (2021). Histoplasmosis in an off-trail Hiker receiving ustekinumab: Implications for Preventive and diagnostic strategies for patients receiving anti-IL-12/23 therapy. Medical mycology case reports, 3243-46. https://doi.org/10.1016/j.mmcr.2021.03.004
Huang, Yun-Han, et al. "Histoplasmosis in an off-trail Hiker receiving ustekinumab: Implications for Preventive and diagnostic strategies for patients receiving anti-IL-12/23 therapy." Medical mycology case reports vol. 32 (2021): 43-46. doi: https://doi.org/10.1016/j.mmcr.2021.03.004
Huang YH, Magleby R, Rao R, Walsh TJ, Singh HK. Histoplasmosis in an off-trail Hiker receiving ustekinumab: Implications for Preventive and diagnostic strategies for patients receiving anti-IL-12/23 therapy. Med Mycol Case Rep. 2021 Mar 13;32:43-46. doi: 10.1016/j.mmcr.2021.03.004. eCollection 2021 Jun. PMID: 33816098; PMCID: PMC8010353.
Copy Download .nbib Format: NLM
The Durability of EUS-Guided Chemoablation of Mucinous Pancreatic Cysts: A Long-Term Follow-Up of the CHARM trial.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Lester C, Walsh L, Hartz KM, Mathew A, Levenick JM, Headlee BD, Heisey HD, Birkholz JH, Dixon M, Maranki JL, Gusani NJ, Dye CE, Moyer MT.
PMID: 33813070
Clin Gastroenterol Hepatol. 2022 Feb;20(2):e326-e329. doi: 10.1016/j.cgh.2021.03.041. Epub 2021 Apr 01.

Pancreatic cancer has known precursor lesions with potential to develop into malignancy over time. At least 20% of pancreatic cancer evolves from mucinous cystic neoplasms and intraductal papillary mucinous neoplasms, which are often discovered incidentally.

Cite
Lester C, Walsh L, Hartz KM, et al. The Durability of EUS-Guided Chemoablation of Mucinous Pancreatic Cysts: A Long-Term Follow-Up of the CHARM trial. Clin Gastroenterol Hepatol. 2021;20(2):e326-e329doi: 10.1016/j.cgh.2021.03.041.
Lester, C., Walsh, L., Hartz, K. M., Mathew, A., Levenick, J. M., Headlee, B. D., Heisey, H. D., Birkholz, J. H., Dixon, M., Maranki, J. L., Gusani, N. J., Dye, C. E., & Moyer, M. T. (2022). The Durability of EUS-Guided Chemoablation of Mucinous Pancreatic Cysts: A Long-Term Follow-Up of the CHARM trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 20(2), e326-e329. https://doi.org/10.1016/j.cgh.2021.03.041
Lester, Courtney, et al. "The Durability of EUS-Guided Chemoablation of Mucinous Pancreatic Cysts: A Long-Term Follow-Up of the CHARM trial." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 20,2 (2022): e326-e329. doi: https://doi.org/10.1016/j.cgh.2021.03.041
Lester C, Walsh L, Hartz KM, Mathew A, Levenick JM, Headlee BD, Heisey HD, Birkholz JH, Dixon M, Maranki JL, Gusani NJ, Dye CE, Moyer MT. The Durability of EUS-Guided Chemoablation of Mucinous Pancreatic Cysts: A Long-Term Follow-Up of the CHARM trial. Clin Gastroenterol Hepatol. 2022 Feb;20(2):e326-e329. doi: 10.1016/j.cgh.2021.03.041. Epub 2021 Apr 01. PMID: 33813070; PMCID: PMC8530455.
Copy Download .nbib Format: NLM
Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

The Cochrane database of systematic reviews

Walsh T, Warnakulasuriya S, Lingen MW, Kerr AR, Ogden GR, Glenny AM, Macey R.
PMID: 34891214
Cochrane Database Syst Rev. 2021 Dec 10;12:CD010173. doi: 10.1002/14651858.CD010173.pub3.

BACKGROUND: The early detection of oral cavity squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD), followed by appropriate treatment, may improve survival and reduce the risk for malignant transformation respectively. This is an update of a Cochrane...

Cite
Walsh T, Warnakulasuriya S, Lingen MW, et al. Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2021;12:CD010173doi: 10.1002/14651858.CD010173.pub3.
Walsh, T., Warnakulasuriya, S., Lingen, M. W., Kerr, A. R., Ogden, G. R., Glenny, A. M., & Macey, R. (2021). Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. The Cochrane database of systematic reviews, 12CD010173. https://doi.org/10.1002/14651858.CD010173.pub3
Walsh, Tanya, et al. "Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults." The Cochrane database of systematic reviews vol. 12 (2021): CD010173. doi: https://doi.org/10.1002/14651858.CD010173.pub3
Walsh T, Warnakulasuriya S, Lingen MW, Kerr AR, Ogden GR, Glenny AM, Macey R. Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2021 Dec 10;12:CD010173. doi: 10.1002/14651858.CD010173.pub3. PMID: 34891214.
Copy Download .nbib Format: NLM
Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes.

The Annals of thoracic surgery

Zhou N, Corsini EM, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC.
PMID: 33838123
Ann Thorac Surg. 2021 Apr 07; doi: 10.1016/j.athoracsur.2021.03.068. Epub 2021 Apr 07.

BACKGROUND: Whether robotic segmentectomies are advantageous is unclear. We describe our experience with the robot, comparing patient populations and outcomes with video-assisted thoracoscopic surgery (VATS) and open resection.METHODS: Patients who underwent anatomic segmentectomy from 2004 to 2019 were reviewed....

Cite
Zhou N, Corsini EM, Antonoff MB, et al. Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes. Ann Thorac Surg. 2021;doi: 10.1016/j.athoracsur.2021.03.068.
Zhou, N., Corsini, E. M., Antonoff, M. B., Hofstetter, W. L., Mehran, R. J., Rajaram, R., Roth, J. A., Sepesi, B., Swisher, S. G., Vaporciyan, A. A., Walsh, G. L., & Rice, D. C. (2021). Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes. The Annals of thoracic surgery, . https://doi.org/10.1016/j.athoracsur.2021.03.068
Zhou, Nicolas, et al. "Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes." The Annals of thoracic surgery vol. (2021). doi: https://doi.org/10.1016/j.athoracsur.2021.03.068
Zhou N, Corsini EM, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes. Ann Thorac Surg. 2021 Apr 07; doi: 10.1016/j.athoracsur.2021.03.068. Epub 2021 Apr 07. PMID: 33838123.
Copy Download .nbib Format: NLM
"The Back-up Vasectomy Reversal." Simultaneous Sperm Retrieval and Vasectomy Reversal in the Couple With Advanced Maternal Age: A Cost-Effectiveness Analysis.

Urology

Cheng PJ, Kim J, Craig JR, Alukal J, Pastuszak AW, Walsh TJ, Hotaling JM.
PMID: 33812879
Urology. 2021 Jul;153:175-180. doi: 10.1016/j.urology.2021.03.021. Epub 2021 Apr 02.

OBJECTIVE: To determine the cost-effectiveness of different fertility options in men who have undergone vasectomy in couples with a female of advanced maternal age (AMA). The options include vasectomy reversal (VR), sperm retrieval (SR) with in vitro fertilization (IVF),...

Cite
Cheng PJ, Kim J, Craig JR, et al. "The Back-up Vasectomy Reversal." Simultaneous Sperm Retrieval and Vasectomy Reversal in the Couple With Advanced Maternal Age: A Cost-Effectiveness Analysis. Urology. 2021;153:175-180doi: 10.1016/j.urology.2021.03.021.
Cheng, P. J., Kim, J., Craig, J. R., Alukal, J., Pastuszak, A. W., Walsh, T. J., & Hotaling, J. M. (2021). "The Back-up Vasectomy Reversal." Simultaneous Sperm Retrieval and Vasectomy Reversal in the Couple With Advanced Maternal Age: A Cost-Effectiveness Analysis. Urology, 153175-180. https://doi.org/10.1016/j.urology.2021.03.021
Cheng, Philip J, et al. ""The Back-up Vasectomy Reversal." Simultaneous Sperm Retrieval and Vasectomy Reversal in the Couple With Advanced Maternal Age: A Cost-Effectiveness Analysis." Urology vol. 153 (2021): 175-180. doi: https://doi.org/10.1016/j.urology.2021.03.021
Cheng PJ, Kim J, Craig JR, Alukal J, Pastuszak AW, Walsh TJ, Hotaling JM. "The Back-up Vasectomy Reversal." Simultaneous Sperm Retrieval and Vasectomy Reversal in the Couple With Advanced Maternal Age: A Cost-Effectiveness Analysis. Urology. 2021 Jul;153:175-180. doi: 10.1016/j.urology.2021.03.021. Epub 2021 Apr 02. PMID: 33812879.
Copy Download .nbib Format: NLM
Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

The Cochrane database of systematic reviews

Walsh T, Warnakulasuriya S, Lingen MW, Kerr AR, Ogden GR, Glenny AM, Macey R.
PMID: 34891214
Cochrane Database Syst Rev. 2021 Dec 10;12:CD010173. doi: 10.1002/14651858.CD010173.pub3.

BACKGROUND: The early detection of oral cavity squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD), followed by appropriate treatment, may improve survival and reduce the risk for malignant transformation respectively. This is an update of a Cochrane...

Cite
Walsh T, Warnakulasuriya S, Lingen MW, et al. Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2021;12:CD010173doi: 10.1002/14651858.CD010173.pub3.
Walsh, T., Warnakulasuriya, S., Lingen, M. W., Kerr, A. R., Ogden, G. R., Glenny, A. M., & Macey, R. (2021). Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. The Cochrane database of systematic reviews, 12CD010173. https://doi.org/10.1002/14651858.CD010173.pub3
Walsh, Tanya, et al. "Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults." The Cochrane database of systematic reviews vol. 12 (2021): CD010173. doi: https://doi.org/10.1002/14651858.CD010173.pub3
Walsh T, Warnakulasuriya S, Lingen MW, Kerr AR, Ogden GR, Glenny AM, Macey R. Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2021 Dec 10;12:CD010173. doi: 10.1002/14651858.CD010173.pub3. PMID: 34891214; PMCID: PMC8664456.
Copy Download .nbib Format: NLM
Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors.

Nature chemistry

Brem J, Panduwawala T, Hansen JU, Hewitt J, Liepins E, Donets P, Espina L, Farley AJM, Shubin K, Campillos GG, Kiuru P, Shishodia S, Krahn D, Leśniak RK, Schmidt Adrian J, Calvopiña K, Turrientes MC, Kavanagh ME, Lubriks D, Hinchliffe P, Langley GW, Aboklaish AF, Eneroth A, Backlund M, Baran AG, Nielsen EI, Speake M, Kuka J, Robinson J, Grinberga S, Robinson L, McDonough MA, Rydzik AM, Leissing TM, Jimenez-Castellanos JC, Avison MB, Da Silva Pinto S, Pannifer AD, Martjuga M, Widlake E, Priede M, Hopkins Navratilova I, Gniadkowski M, Belfrage AK, Brandt P, Yli-Kauhaluoma J, Bacque E, Page MGP, Björkling F, Tyrrell JM, Spencer J, Lang PA, Baranczewski P, Cantón R, McElroy SP, Jones PS, Baquero F, Suna E, Morrison A, Walsh TR, Schofield CJ.
PMID: 34903857
Nat Chem. 2021 Dec 13; doi: 10.1038/s41557-021-00831-x. Epub 2021 Dec 13.

Carbapenems are vital antibiotics, but their efficacy is increasingly compromised by metallo-β-lactamases (MBLs). Here we report the discovery and optimization of potent broad-spectrum MBL inhibitors. A high-throughput screen for NDM-1 inhibitors identified indole-2-carboxylates (InCs) as potential β-lactamase stable β-lactam...

Cite
Brem J, Panduwawala T, Hansen JU, et al. Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors. Nat Chem. 2021;doi: 10.1038/s41557-021-00831-x.
Brem, J., Panduwawala, T., Hansen, J. U., Hewitt, J., Liepins, E., Donets, P., Espina, L., Farley, A. J. M., Shubin, K., Campillos, G. G., Kiuru, P., Shishodia, S., Krahn, D., Leśniak, R. K., Schmidt Adrian, J., Calvopiña, K., Turrientes, M. C., Kavanagh, M. E., Lubriks, D., Hinchliffe, P., Langley, G. W., Aboklaish, A. F., Eneroth, A., Backlund, M., Baran, A. G., Nielsen, E. I., Speake, M., Kuka, J., Robinson, J., Grinberga, S., Robinson, L., McDonough, M. A., Rydzik, A. M., Leissing, T. M., Jimenez-Castellanos, J. C., Avison, M. B., Da Silva Pinto, S., Pannifer, A. D., Martjuga, M., Widlake, E., Priede, M., Hopkins Navratilova, I., Gniadkowski, M., Belfrage, A. K., Brandt, P., Yli-Kauhaluoma, J., Bacque, E., Page, M. G. P., Björkling, F., Tyrrell, J. M., Spencer, J., Lang, P. A., Baranczewski, P., Cantón, R., McElroy, S. P., Jones, P. S., Baquero, F., Suna, E., Morrison, A., Walsh, T. R., & Schofield, C. J. (2021). Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors. Nature chemistry, . https://doi.org/10.1038/s41557-021-00831-x
Brem, Jürgen, et al. "Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors." Nature chemistry vol. (2021). doi: https://doi.org/10.1038/s41557-021-00831-x
Brem J, Panduwawala T, Hansen JU, Hewitt J, Liepins E, Donets P, Espina L, Farley AJM, Shubin K, Campillos GG, Kiuru P, Shishodia S, Krahn D, Leśniak RK, Schmidt Adrian J, Calvopiña K, Turrientes MC, Kavanagh ME, Lubriks D, Hinchliffe P, Langley GW, Aboklaish AF, Eneroth A, Backlund M, Baran AG, Nielsen EI, Speake M, Kuka J, Robinson J, Grinberga S, Robinson L, McDonough MA, Rydzik AM, Leissing TM, Jimenez-Castellanos JC, Avison MB, Da Silva Pinto S, Pannifer AD, Martjuga M, Widlake E, Priede M, Hopkins Navratilova I, Gniadkowski M, Belfrage AK, Brandt P, Yli-Kauhaluoma J, Bacque E, Page MGP, Björkling F, Tyrrell JM, Spencer J, Lang PA, Baranczewski P, Cantón R, McElroy SP, Jones PS, Baquero F, Suna E, Morrison A, Walsh TR, Schofield CJ. Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors. Nat Chem. 2021 Dec 13; doi: 10.1038/s41557-021-00831-x. Epub 2021 Dec 13. PMID: 34903857.
Copy Download .nbib Format: NLM
Showing 613 to 621 of 621 entries